Ashish Verma to Diabetes Mellitus, Type 2
This is a "connection" page, showing publications Ashish Verma has written about Diabetes Mellitus, Type 2.
Connection Strength
2.275
-
Solomon M, Claudel S, Verma A. Cardiovascular-Kidney-Metabolic Health: Definition, Staging, Risk Assessment, and Therapeutic Considerations. Cardiol Clin. 2025 Aug; 43(3):337-357.
Score: 0.573
-
Patel AB, Mistry K, Verma A. DAPA-CKD: Significant Victory for CKD with or without Diabetes. Trends Endocrinol Metab. 2021 06; 32(6):335-337.
Score: 0.431
-
Verma A, Patel AB. Finerenone: A Non-steroidal Mineralocorticoid Receptor Blocker for Diabetic Kidney Disease. Trends Endocrinol Metab. 2021 05; 32(5):261-263.
Score: 0.430
-
Verma A, Patel AB, Waikar SS. SGLT2 Inhibitor: Not a Traditional Diuretic for Heart Failure. Cell Metab. 2020 07 07; 32(1):13-14.
Score: 0.411
-
Verma A, Patel AB, Upadhyay A, Waikar SS. CREDENCE: Significant Victory for Diabetic Kidney Disease. Trends Endocrinol Metab. 2020 06; 31(6):391-393.
Score: 0.405
-
Pandey D, Verma A, Ding Y, Singh P, Magoo H. Acute oxalate nephropathy associated with Clostridiumdifficile infection. BMJ Case Rep. 2019 Dec 05; 12(12).
Score: 0.025